Parkinson’s UK and Parkinson’s Foundation partner up to speed up the search for new treatments Date 23 August 2022 Over the next 3 years, the US-based Parkinson’s Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson’s Virtual Biotech, our international drug discovery and development programme.
Disappointing results from trials of vaccines for Parkinson’s, but hope for the future Date 12 August 2022 2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
Cost of living support and what it means for the Parkinson's community Date 4 August 2022 A summary of the chancellor's cost of living support and what it means for people with Parkinson's.
Celebrating neuroscience in spring 2023 Date 4 August 2022 We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
Work and Pensions Committee concerned about impact of the cost of living crisis on disabled people Date 27 July 2022 Parliament's Work and Pensions Committee have shared their concerns about the impact of the cost of living crisis on disabled people and urged government action to review the level of benefits.
Parkinson’s UK celebrity ambassador David ‘Kid’ Jensen takes part in world-first clinical trial Date 22 July 2022 Broadcasting legend and Parkinson's UK celebrity ambassador David ‘Kid’ Jensen is taking part in a world-first clinical trial. The trial will help researchers understand if an anti-sickness drug could treat hallucinations in people with Parkinson’s or Lewy body dementia.
More healthcare professionals can now assess fitness to drive Date 20 July 2022 A change to the law in England, Scotland and Wales means a wider range of healthcare professionals can now assess fitness to drive. We hope this will speed up people being able to get their driving licences.
Caption People sit around a table for a group discussion Understanding symptoms early after Parkinson’s diagnosis Date 19 July 2022 An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.
British designer, Eleanor Bowmer, teams with Next to ‘Let love shine’ for exclusive collaboration in support of Parkinson’s UK Date 11 July 2022 100% of the profits from Next’s new collection, designed by Eleanor Bowmer, will help fund support for the Parkinson’s community.
